Spinocerebellar Ataxia 2012
DOI: 10.5772/28576
|View full text |Cite
|
Sign up to set email alerts
|

Machado-Joseph Disease / Spinocerebellar Ataxia Type 3

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2019
2019
2021
2021

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 244 publications
(263 reference statements)
0
2
0
Order By: Relevance
“…For Experiment 2, three marmosets (three males, aged 184 ± 1.4 days) were recruited from the polyglutamine disease model transgenic marmoset line (second generation) recently established in our laboratory (Tomioka et al, 2017). Polyglutamine diseases are heritable neurodegenerative disorders caused by expansion of trinucleotide repeats for the polyglutamine tract (Nóbrega and De Almeida, 2012). This animal model typically shows a variety of motor disease symptoms characterized by progressively lower daily activity (Tomioka et al, 2017).…”
Section: Animalsmentioning
confidence: 99%
See 1 more Smart Citation
“…For Experiment 2, three marmosets (three males, aged 184 ± 1.4 days) were recruited from the polyglutamine disease model transgenic marmoset line (second generation) recently established in our laboratory (Tomioka et al, 2017). Polyglutamine diseases are heritable neurodegenerative disorders caused by expansion of trinucleotide repeats for the polyglutamine tract (Nóbrega and De Almeida, 2012). This animal model typically shows a variety of motor disease symptoms characterized by progressively lower daily activity (Tomioka et al, 2017).…”
Section: Animalsmentioning
confidence: 99%
“…Motility declines following functional deterioration of multiple body parts (Ferrucci et al, 2016;Buchman et al, 2018). Movement disorder often accompanies certain neurologic diseases (Taroni and Didonato, 2004;Nóbrega and De Almeida, 2012), severely limiting an individual's viability (Barlow et al, 1996;Robinson et al, 2013). Behavioral phenotyping of experimental animal models of human disease aims to quantitatively characterize the motor behavior and its disease-specific deviation from healthy animals (Lin et al, 2001;Pratte et al, 2011;Urbach et al, 2014).…”
Section: Introductionmentioning
confidence: 99%